Nov 12, 2021 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 FY '22 Earnings Conference Call of NATCO Pharma hosted by Investec Capital Services. (Operator Instructions) And there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) I now hand the conference over to Ms. Swapna Bhandarkar for Investec Capital Services. Thank you, and over to you, ma'am.
Swapna Bhandarkar -
Thanks, Jacob, and Good morning, everybody. Firstly, let me apologize for the delay. We were facing some technical issue on our side. Having said that, I welcome all to the Q2 FY '22 earnings call of NATCO Pharma. We have with us the management of the company, Mr. Rajeev Nannapaneni. He's the Vice Chairman and Executive -- Chief Executive Officer. Joining him is Mr. Rajesh Chebiyam. He's the EVP and for Crop Health Sciences and Head of Investor Relations. Good morning, gentlemen, and I now hand over this call to Mr. Rajeev to make the opening remarks, post which we will begin the Q&A session. Thank you.
Rajeev Nannapaneni -
Q2 2022 Natco Pharma Ltd Earnings Call Transcript
Nov 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers